GlassScriptPrepare for your visit
Darlene Negbenebor
Stamford, CT · NPI 1891728853
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$24,753.40
in general payments reported to CMS, 2019-2025 · $5,553 in 2025
The $5,553 reported for 2025 was more than what 98% of providers received nationally.
Who reported paying
General payments only, top 6 by amount.
- Salix Pharmaceuticals, A Division of Bausch Health US, LLC $5,928.53
- Abbvie INC. $4,708.44
- Janssen Biotech, INC. $1,604.10
- Pfizer INC. $1,465.33
- Qol Medical, LLC $1,273.24
- Ironwood Pharmaceuticals, INC $1,251.02
Drugs and devices associated with these payments
Linzess Xifaxan Rinvoq Voquezna Sucraid Skyrizi Ibsrela Tremfya Iqirvo Creon Entyvio Stelara
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Darlene Negbenebor listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/267573/darlene-negbenebor